CFDE Data Portal | Search ATP13A1

	Label	Description
	ATP13A1 associations Collection (Entity type)	Associations for ATP13A1_associations
	ATP13A1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ATP13A1 Gene (Entity type)	ENSG00000105726 - ATPase 13A1
	KFGENEBIN:ATP13A1-variant-count CUI gene has variants ATP13A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE261563 CX-5461 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135030 3 V 10 FLUDARABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 gemcitabine 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE168596 2 V 3 ADIPONECTIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE165960 MEK inhibition 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

ATP13A1 associations

Associations for ATP13A1_associations

ATP13A1 associations.tsv

A file from IDG as part of the Harmonizome project

ATP13A1

ENSG00000105726 - ATPase 13A1

KFGENEBIN:ATP13A1-variant-count CUI gene has variants ATP13A1

A Knowledge Graph Assertion from Kids First

GSE261563 CX-5461 6 v 1 human up

A Gene Set from LINCS

GSE135030 3 V 10 FLUDARABINE HUMAN UP

A Gene Set from LINCS

GSE113655 phenol 1 v 2 human dn

A Gene Set from LINCS

GSE165548 gemcitabine 2 v 5 human up

A Gene Set from LINCS

GSE168596 2 V 3 ADIPONECTIN MOUSE DN

A Gene Set from LINCS

GSE165960 MEK inhibition 0 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.